C-reactive protein (CRP) in Obese Diabetic Women

Study identifier:DM-CRESTOR-0001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Interventions study for the control of diabetes mellitus type 2 in obese women

Medical condition

Diabetes Mellitus, Type 2

Phase

Phase 4

Healthy volunteers

Study drug

Rosuvastatin; improvement of lipid profile

Sex

Female

Actual Enrollment

100

Study type

Interventional

Age

45 Years +

Date

Study Start Date: 01 Oct 2005

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Aug 2007 by AstraZeneca Pharmaceuticals

Collaborators

Mexican National Institute of Public Health

Inclusion and exclusion criteria

Location

Research site

Cuernavaca, Morelos, Mexico

Arms	Assigned Interventions

Documents available

Trial Results Summaries
Available here

Contacts

Contact

Simón Barquera Cervera

(777) 329-3000

Contact Backup